On June 3, 2013, the results of the Pomi-T study were shared at the Annual Meeting of the American Society of Clinical Oncology (ASCO). The study examined the beneficial effects of Pomi-T, a dietary supplement, on prostate specific antigen. The results were so impressive that the dietary supplement has been flying off the shelves!
The randomized, controlled trial included 203 men with a history of prostate cancer. The average age of the men was 74. The men were separated into two groups: The treatment group and the placebo group. The treatment group received two Pomi-T capsules daily for six months, which contained broccoli, turmeric, pomegranate seed powder and green tea extract.
At trial completion, 46 percent of the men in the supplement group had a stable or lower PSA compared to only 14 percent in the placebo group. The median rise in PSA for men taking the supplement was 14.7 percent, while the placebo group experienced a 78.5 percent increase in PSA -- the 63.8 percent difference was statistically significant.
These results are fascinating, but leave many unanswered questions. Patients may wonder if the lower PSA translates into progression-free survival. Healthcare professionals may inquire about the ability to replicate these results in a larger clinical trial; others may wonder if an over-the-counter supplement can truly have any of these anticancer, protective effects.
Taking dietary supplements to prevent cancer is not routinely recommended. As a matter of fact, the American Institute for Cancer Research (AICR) advises cancer patients and survivors to aim to meet nutritional needs through diet alone.1 AICR recognizes that some people may benefit from dietary supplements, like those at risk for vitamin deficiency, but cautions against using supplements to protect against cancer.2
What are your thoughts? If you had a loved one with a history of prostate cancer, would you recommend Pomi-T now, or wait for evidence-based guidelines?